ALI FARAZ (Chief Executive Officer) sold 3.2% of their position (14.86K shares) of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/17/2026ACC: 0001193125-26-055442
DirectorOfficer· Chief Executive Officer
Since Jul 2021
-14.86K
Net shares
Net seller
$9.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
14.86K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−5.85K
Price / share
$0.64
Trade value
$3.76K
% of position
1.3%
2/17/2026
458.27K→452.42K
Common Stock
Direct
Shares
−3.98K
Price / share
$0.64
Trade value
$2.56K
% of position
0.9%
2/17/2026
452.42K→448.44K
Common Stock
Direct
Shares
−5.03K
Price / share
$0.64
Trade value
$3.24K
% of position
1.1%
2/17/2026
448.44K→443.40K
Total
Net shares
−14.86K
Net value
-$9.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | S · Sale | −5.85K | $0.64 | $3.76K | 1.3% | 458.27K | 452.42K |
| Common Stock Direct | 2/17/2026 | S · Sale | −3.98K | $0.64 | $2.56K | 0.9% | 452.42K | 448.44K |
| Common Stock Direct | 2/17/2026 | S · Sale | −5.03K | $0.64 | $3.24K | 1.1% | 448.44K | 443.40K |
| Total | −14.86K | -$9.56K | ||||||
Derivative Transactions0
No derivative transactions reported